Literature DB >> 29176593

Shared genetic etiology of hypertension and stroke: evidence from bioinformatics analysis of genome-wide association studies.

L D Ji1,2, S P Hu3, J Y Li4, B B Yao5, Q J Shen6,7, J Xu8,9.   

Abstract

Hypertension is the most significant modifiable risk factor for cerebrovascular disease. It has been estimated that about 54% of strokes worldwide can be attributed to hypertension. However, there has not been a systematic study assessing the shared genetic susceptibility to hypertension and stroke on a genome-wide level. In this study, SNPs associated with essential hypertension and stroke were collected from the NHGRI-EBI GWAS catalog, and genotype imputation were conducted using information from the 1000 Genomes Project. Subsequently, the SNPs and the mapped genes were compared between the two diseases. Finally, functional clustering was performed, and the enriched GO terms and KEGG pathways were further compared between hypertension and stroke. Comparison of these two groups of SNPs and genes identified only one shared SNP (rs3184504) and 11 shared genes. After genotype imputation, 129 shared SNPs and 16 shared genes were identified. These genes were significantly enriched in 10 GO terms, which were mainly involved in lipoprotein and triglyceride metabolism. Additionally, KEGG analysis identified one pathway, glycerolipid metabolism, as being significantly enriched in both diseases. The present study strongly suggests that the gene network regulating lipid metabolism and blood circulation is the major shared genetic etiology of hypertension and stroke.

Entities:  

Mesh:

Year:  2017        PMID: 29176593     DOI: 10.1038/s41371-017-0012-3

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  22 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Genetic basis of blood pressure and hypertension.

Authors:  Sandosh Padmanabhan; Christopher Newton-Cheh; Anna F Dominiczak
Journal:  Trends Genet       Date:  2012-05-21       Impact factor: 11.639

3.  LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.

Authors:  Wei Wang; Yang Tang; Ying Wang; Liana Tascau; Joanna Balcerek; Wei Tong; Ross L Levine; Carrie Welch; Alan R Tall; Nan Wang
Journal:  Circ Res       Date:  2016-07-18       Impact factor: 17.367

Review 4.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

5.  Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.

Authors:  Nathan P Rudemiller; Hayley Lund; Jessica R C Priestley; Bradley T Endres; Jeremy W Prokop; Howard J Jacob; Aron M Geurts; Eric P Cohen; David L Mattson
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

Review 6.  Genotype imputation.

Authors:  Yun Li; Cristen Willer; Serena Sanna; Gonçalo Abecasis
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

7.  Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.

Authors:  Katherine T Mills; Joshua D Bundy; Tanika N Kelly; Jennifer E Reed; Patricia M Kearney; Kristi Reynolds; Jing Chen; Jiang He
Journal:  Circulation       Date:  2016-08-09       Impact factor: 29.690

8.  Genome-wide association study of blood pressure and hypertension.

Authors:  Daniel Levy; Georg B Ehret; Kenneth Rice; Germaine C Verwoert; Lenore J Launer; Abbas Dehghan; Nicole L Glazer; Alanna C Morrison; Andrew D Johnson; Thor Aspelund; Yurii Aulchenko; Thomas Lumley; Anna Köttgen; Ramachandran S Vasan; Fernando Rivadeneira; Gudny Eiriksdottir; Xiuqing Guo; Dan E Arking; Gary F Mitchell; Francesco U S Mattace-Raso; Albert V Smith; Kent Taylor; Robert B Scharpf; Shih-Jen Hwang; Eric J G Sijbrands; Joshua Bis; Tamara B Harris; Santhi K Ganesh; Christopher J O'Donnell; Albert Hofman; Jerome I Rotter; Josef Coresh; Emelia J Benjamin; André G Uitterlinden; Gerardo Heiss; Caroline S Fox; Jacqueline C M Witteman; Eric Boerwinkle; Thomas J Wang; Vilmundur Gudnason; Martin G Larson; Aravinda Chakravarti; Bruce M Psaty; Cornelia M van Duijn
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

9.  Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1982-02-05       Impact factor: 56.272

10.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants.

Authors:  Lucas D Ward; Manolis Kellis
Journal:  Nucleic Acids Res       Date:  2011-11-07       Impact factor: 16.971

View more
  3 in total

1.  Genome-Wide Screen of the Hippocampus in Aged Rats Identifies Mitochondria, Metabolism and Aging Processes Implicated in Sevoflurane Anesthesia.

Authors:  Yujie Wang; Min Qian; Yinyin Qu; Ning Yang; Bing Mu; Kaixi Liu; Jing Yang; Yang Zhou; Cheng Ni; Jing Zhong; Xiangyang Guo
Journal:  Front Aging Neurosci       Date:  2020-05-07       Impact factor: 5.750

2.  Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia.

Authors:  Youhyun Song; Ja-Eun Choi; Yu-Jin Kwon; Hyuk-Jae Chang; Jung Oh Kim; Da-Hyun Park; Jae-Min Park; Seong-Jin Kim; Ji Won Lee; Kyung-Won Hong
Journal:  J Transl Med       Date:  2021-02-25       Impact factor: 5.531

3.  Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Authors:  Mindi Zhao; Xiaoyan Liu; Xiaoxiao Bu; Yao Li; Meng Wang; Bo Zhang; Wei Sun; Chuanbao Li
Journal:  PeerJ       Date:  2022-08-09       Impact factor: 3.061

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.